+1,935.5%
KLAC vs GSK
+97.7%
+1,837.8%
-56.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -1.6% | -0.8% | -1.8% |
| 7D | -9.9% | -4.7% | -5.2% | -8.3% |
| 30D | -12.4% | -4.7% | -7.7% | -11.1% |
| 3M | -24.3% | -8.8% | -15.6% | -22.2% |
| 6M | -18.5% | -4.6% | -13.9% | -18.5% |
| YTD | +17.0% | +1.0% | +16.1% | +13.2% |
| 1Y | +21.8% | +6.9% | +14.9% | +14.8% |
| 3Y | +165.7% | +52.5% | +113.2% | +100.6% |
| 5Y | +251.3% | +40.3% | +211.0% | +169.4% |
| All | +1,935.5% | +97.7% | +1,837.8% | +1,217.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling